KWS Saat this year on track for record sales

Tomorrow the German KWS Saat will publish her past quarter's figures. Based on the analysts' consensus: both the revenue and the net result would be the highest in years. Over the current book year the total revenue will be 1,15 billion euros (consensus estimates). The expected revenue would be a record for the company. This is slightly more than 2016's revenue of 1,08 billion euros.

Historical revenues and results KWS Saat plus estimates 2017

The analysts anticipate for 2017 a record net profit a 105 million euros. The majority of the analysts expects for this year a profit per share of 15,83 euros. Based on this the price/earnings-ratio is 21,85.

For this year the analysts expect a dividend of 3,42 euros per share. The dividend yield is then 0,99 percent. The average dividend yield of the biotech companies equals a limited 0,06 percent.

Recent target prices around 336 euros

The most recent recommendations for the biotech company are from M.M. Warburg & Co., Equinet-ag and DZ Bank.

KWS Saat 's market value equals around 2,28 billion .

At 9.51 the stock trades 1,27 percent higher at 345,9 euros.

Historical stock prices KWS Saat

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.